Family medicine residents’ knowledge and opinions towards deprescribing

Authors

  • Margarida Gonçalinho Almeida Médica Interna de Formação Geral. ULS Viseu – Dão Lafões. Viseu, Portugal.
  • Pedro Simões Médico de Medicina Geral e Familiar. UCSP Fundão. Fundão, Portugal | Faculdade de Ciências da Saúde da Universidade da Beira Interior. Covilhã, Portugal.
  • Inês Rosendo Médica de Medicina Geral e Familiar. USF Coimbra Centro. Coimbra, Portugal | Faculdade de Medicina da Universidade de Coimbra. Coimbra, Portugal.
  • Luís Monteiro Médico de Medicina Geral e Familiar. USF Esgueira+, ULS Região de Aveiro. Aveiro, Portugal | CINTESIS - Centre for Health Technology and Services Research, Faculdade de Medicina da Universidade do Porto. Porto, Portugal | Department of Medical Sciences, University of Aveiro. Aveiro, Portugal.

DOI:

https://doi.org/10.32385/rpmgf.v40i4.13736

Keywords:

Deprescribing, Polypharmacotherapy, Potentially inappropriate medication list, Multimorbidity

Abstract

Aims: This study aims to know the perception of the family medicine residents concerning their personal opinions and knowledge about deprescription.

Methods: Cross-sectional study. The data was collected through a survey sent to interns of family medicine across the country by email. The survey contained three open questions, twenty-two statements to classify using a 5-point Likert scale, five multiple choice sociodemographic questions, and whether deprescription has been a subject discussed in their professional journey and at what stage.

Results: One hundred and six valid answers were obtained: 76.4% were female, 70.8% were between 25 and 30 years old, and 34% were first-year family medicine residents. Most of the participants agree that deprescribing is beneficial and the barriers include health literacy, time per appointment, and the lack of information for doctors and patients.

Conclusion: The results underline how important deprescribing is for the residents and the need to adopt strategies for its implementation. It is important to deepen the theme to determine how to have easier adherence from the patient and to create guidelines that help doctors optimize deprescribing. 

Downloads

Download data is not yet available.

References

Pordata. Índice de envelhecimento: que países têm mais e menos idosos por 100 jovens? [homepage]. Fundação Francisco Manuel dos Santos; 2022 [updated 2024 Feb 2; cited 2022 Dec 13]. Available from: https://prod2.pordata.pt/europa/indice+de+envelhecimento-1609

Eurostat. Active ageing and solidarity between generations: a statistical portrait of the European Union 2012. Luxembourg: Publications Office of the European Union; 2011. ISBN 978-92-79-21507-0

Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11):e15385.

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

Simões PA, Santiago LM, Simões JA. Prevalence of polypharmacy in the older adult population within primary care in Portugal: a nationwide cross-sectional study. Arch Med Sci. 2024;20(4).

Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32-8.

Monteiro L, Maricoto T, Solha IS, Monteiro-Soares M, Martins C. Computerised decision to reduce inappropriate medication in the elderly: a systematic review with meta-analysis protocol. BMJ Open. 2018;8(1):e018988.

Simões PA. Deprescribing: a self-portrait about the reduction of polypharmacy in Portugal [dissertation]. Covilhã: Faculdade de Ciências da Saúde da Universidade da Beira Interior; 2020. Available from: http://hdl.handle.net/10400.6/11164

Williams S, Miller G, Khoury R, Grossberg GT. Rational deprescribing in the elderly. Ann Clin Psychiatry. 2019;31(2):144-52.

Jungo KT, Mantelli S, Rozsnyai Z, Missiou A, Kitanovska BG, Weltermann B, et al. General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. BMC Geriatr. 2021;21(1):19.

Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, et al. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3323-32.

van Poelgeest EP, Seppala LJ, Lee JM, Bahat G, Ilhan B, Lavan AH, et al. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey. Eur Geriatr Med. 2022;13(6):1455-66.

Rodrigues DA, Plácido AI, Tavares AB, Azevedo D, Mateos-Campos R, Figueiras A, et al. Potentially inappropriate medication prescribing in older adults according to EU(7)-Potentially Inappropriate Medication List: a nationwide study in Portugal. Curr Ther Res Clin Exp. 2022;97:100681.

Published

2024-09-16

How to Cite

Family medicine residents’ knowledge and opinions towards deprescribing. (2024). Portuguese Journal of Family Medicine and General Practice, 40(4), 353-62. https://doi.org/10.32385/rpmgf.v40i4.13736

Most read articles by the same author(s)

1 2 > >>